Rybelsus Semaglutide 3mg/7mg/14mg Tablets ₹ 3300 / Stripe Get Latest Price Product Brochure Form Tablets Packaging size 10*10 Tablets Packaging Type Strip Brand Rybelsus Shelf Life 24 Months Prescription/Non prescription Prescription Usuage to treat type 2 diabetes Prescription / Non Prescription Prescription Country of Origin Made in India Dose/Strength 3mg/7mg/14mg RYBELSUS® (semaglutide) tablets 3mg, 7 mg or 14 mg is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes. It is not known if RYBELSUS® can be used in people who have had pancreatitis RYBELSUS® is not for use in people with type 1 diabetes It is not known if RYBELSUS® is safe and effective for use in children under 18 years of age Key takeaways: Rybelsus (semaglutide) is an oral medication approved to treat Type 2 diabetes. It contains the same active ingredient as Ozempic and Wegovy. Ozempic is approved for Type 2 diabetes, and Wegovy is approved for chronic weight management. Rybelsus is currently being studied for weight loss in clinical trials. These studies involve higher doses than what’s currently approved and available for diabetes. Results show that an oral semaglutide (Rybelsus) dose of 50 mg results in similar weight loss as Wegovy. Due to these findings, Rybelsus’ manufacturer plans to request FDA approval in 2023. If approved for weight loss, it may be marketed under a different brand name
Send Message